Sponsor Dossier
Chiesi
Sponsor Dossier for Chiesi. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALKINDI
- Brand: ALVESCO
- Brand: ASACOL
- Brand: CLEVIPREX
- Brand: CUROSURF
- Brand: DIACOMIT
- Brand: ELFABRIO
- Brand: ENTOCORT
About
Chiesi is an Australian Private Company with ABN 72 145 180 865, registered in Victoria. The company is active and operates under the trading name Emerge Health.
Portfolio
Chiesi has 15 brands on the ARTG, of which 14 are indexable. Fourteen brands have Product Information on file, eight brands have PBAC outcome records, and five brands have AusPARs on record. Six brands are PBS-listed.
Therapeutic focus
— Respiratory: 5 brands — Immunology: 3 brands — Haematology: 1 brand — Dermatology: 1 brand — Gastroenterology: 1 brand — Endocrinology: 1 brand — Cardiology: 1 brand — Neurology: 1 brand — Women's Health: 1 brand
PBS footprint
Six brands in Chiesi's portfolio are PBS-listed, with the latest schedule date touched on 1 May 2026.
Regulatory activity
Chiesi's latest PBAC outcome is dated 1 December 2025, representing eight brands with PBAC outcomes on record. The latest AusPAR is dated 12 May 2025, with five brands holding AusPARs on record.